Leading lentiviral design and process platform---BDgene's advanced lentiviral vector delivery technology effectively improves the virus production and the infection efficiency of hematopoietic stem cells. BDlenti delivery technology adds a unique optimization strategy that can reduce the risk of gene integration mutations. At the same time, let the therapeutic gene be expressed in the patient's body for a long time without losing the therapeutic effect due to gene silencing.

Related technologies are published in top international journals such as Cell Stem Cell(2024).